Published in Pediatr Infect Dis J on April 01, 2001
Viral strain identification in varicella vaccinees with disseminated rashes. Pediatr Infect Dis J (2000) 1.56
CpG motifs in bacterial DNA trigger direct B-cell activation. Nature (1995) 12.24
DNA vaccines: immunology, application, and optimization*. Annu Rev Immunol (2000) 4.51
Varicella vaccination: evidence for frequent reactivation of the vaccine strain in healthy children. Nat Med (2000) 3.07
Systemic autoimmune disease arises from polyclonal B cell activation. J Exp Med (1987) 2.71
Human peripheral blood cells differentially recognize and respond to two distinct CPG motifs. J Immunol (2001) 2.61
Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes. Lancet (1994) 2.53
Cutting edge: Role of Toll-like receptor 9 in CpG DNA-induced activation of human cells. J Immunol (2001) 2.49
Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria. J Immunol (1999) 2.23
Genomic DNA released by dying cells induces the maturation of APCs. J Immunol (2001) 2.03
A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats. J Virol (1994) 1.86
Human immunodeficiency virus infection induces both polyclonal and virus-specific B cell activation. J Clin Invest (1992) 1.84
Interferon (IFN) consensus sequence-binding protein, a transcription factor of the IFN regulatory factor family, regulates immune responses in vivo through control of interleukin 12 expression. J Exp Med (1997) 1.73
Improved identification and differentiation of varicella-zoster virus (VZV) wild-type strains and an attenuated varicella vaccine strain using a VZV open reading frame 62-based PCR. J Clin Microbiol (2000) 1.63
Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides. J Immunol (1999) 1.58
Distinct patterns of cytokine secretion characterize new onset synovitis versus chronic rheumatoid arthritis. J Rheumatol (1998) 1.55
A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine. J Immunol (1998) 1.54
Activation of target-tissue immune-recognition molecules by double-stranded polynucleotides. Proc Natl Acad Sci U S A (1999) 1.48
Rapid genotyping of varicella-zoster virus vaccine and wild-type strains with fluorophore-labeled hybridization probes. J Clin Microbiol (2000) 1.46
Rapid immune activation by CpG motifs in bacterial DNA. Systemic induction of IL-6 transcription through an antioxidant-sensitive pathway. J Immunol (1996) 1.46
Studies of consomic mice bearing the Y chromosome of the BXSB mouse. J Immunol (1985) 1.44
Postlicensure safety surveillance for varicella vaccine. JAMA (2000) 1.44
The characteristic site-specific reactivation phenotypes of HSV-1 and HSV-2 depend upon the latency-associated transcript region. J Exp Med (1996) 1.41
Recent advances in varicella-zoster virus infection. Ann Intern Med (1999) 1.41
Nucleotide sequences that distinguish Oka vaccine from parental Oka and other varicella-zoster virus isolates. J Infect Dis (2000) 1.40
Sterically stabilized cationic liposomes improve the uptake and immunostimulatory activity of CpG oligonucleotides. J Immunol (2001) 1.33
Autoimmunity and increased c-myb transcription. Science (1984) 1.27
Complexity of the cytokine and antibody response elicited by immunizing mice with Plasmodium yoelii circumsporozoite protein plasmid DNA. J Immunol (1995) 1.24
Microbial products induce autoimmune disease by an IL-12-dependent pathway. J Immunol (1997) 1.21
Protection against anthrax toxin by vaccination with a DNA plasmid encoding anthrax protective antigen. Vaccine (1999) 1.20
CpG oligodeoxynucleotides and interleukin-12 improve the efficacy of Mycobacterium bovis BCG vaccination in mice challenged with M. tuberculosis. Infect Immun (2000) 1.19
Proliferation of anti-DNA-producing NZB B cells in a non-autoimmune environment. J Immunol (1986) 1.17
Oncogene expression in autoimmune and normal peripheral blood mononuclear cells. J Exp Med (1986) 1.15
Induction and enhancement of immune responses to herpes simplex virus type 2 in humans by use of a recombinant glycoprotein D vaccine. J Infect Dis (1993) 1.14
Simultaneous induction of multiple antigen-specific cytotoxic T lymphocytes in nonhuman primates by immunization with a mixture of four Plasmodium falciparum DNA plasmids. Infect Immun (1998) 1.09
Induction of neonatal tolerance by plasmid DNA vaccination of mice. J Clin Invest (1996) 1.08
Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccine. J Pediatr (1995) 1.08
Sequence analysis and expression of an X-linked, lymphocyte-regulated gene family (XLR). J Exp Med (1987) 1.07
Sex hormone levels correlate with the activity of cytokine-secreting cells in vivo. Immunology (2000) 1.06
NIH conference. Systemic lupus erythematosus. Ann Intern Med (1991) 1.06
The 2.2-kilobase latency-associated transcript of herpes simplex virus type 2 does not modulate viral replication, reactivation, or establishment of latency in transgenic mice. J Virol (2001) 1.04
Plasmid DNA encoding transforming growth factor-beta1 suppresses chronic disease in a streptococcal cell wall-induced arthritis model. J Clin Invest (1998) 1.03
Theoretical and experimental approaches to generalized autoimmunity. Immunol Rev (1990) 1.03
Heterogeneous expression and coordinate regulation of endogenous retroviral sequences in human peripheral blood mononuclear cells. AIDS Res Hum Retroviruses (1992) 1.02
Pathogenesis of systemic lupus erythematosus. Rheum Dis Clin North Am (1988) 1.02
CpG motifs of DNA vaccines induce the expression of chemokines and MHC class II molecules on myocytes. Eur J Immunol (2001) 1.01
CpG oligodeoxynucleotides induce murine macrophages to up-regulate chemokine mRNA expression. Cell Immunol (2000) 0.99
Individual cells simultaneously produce both IL-4 and IL-6 in vivo. Cytokine (1994) 0.98
A suppressive oligodeoxynucleotide inhibits ocular inflammation. Clin Exp Immunol (2009) 0.98
IgE receptor-positive non-B/non-T cells dominate the production of interleukin 4 and interleukin 6 in immunized mice. Proc Natl Acad Sci U S A (1995) 0.98
Disassociation of sex hormone levels and cytokine production in SLE patients. Lupus (2001) 0.96
Toward clinical trials of DNA vaccines against malaria. Immunol Cell Biol (1997) 0.95
Do DNA vaccines induce autoimmune disease? Hum Gene Ther (1997) 0.95
Response of peripheral blood mononuclear cells from lupus patients to stimulation by CpG oligodeoxynucleotides. Rheumatology (Oxford) (2003) 0.95
The interaction of the xid and me genes. J Immunol (1987) 0.95
Autoantibody production is associated with polyclonal B cell activation in autoimmune mice which express the lpr or gld genes. Eur J Immunol (1988) 0.95
Activation of microglia and astrocytes by CpG oligodeoxynucleotides. Neuroreport (2001) 0.95
Quantity of latency-associated transcript produced by herpes simplex virus is not predictive of the frequency of experimental recurrent genital herpes. J Infect Dis (1994) 0.94
NIH conference. Angioimmunoblastic lymphadenopathy with dysproteinemia. Ann Intern Med (1988) 0.93
Phenotype and frequency of cells secreting IL-2, IL-4, IL-6, IL-10, IFN and TNF-alpha in human peripheral blood. Cytokine (1995) 0.93
Prime-boost vaccination with plasmid DNA and a chimeric adenovirus type 5 vector with type 35 fiber induces protective immunity against HIV. Gene Ther (2005) 0.92
Murine cytomegalovirus infection-induced polyclonal B cell activation is independent of CD4+ T cells and CD40. Virology (1998) 0.92
Immune responses in asymptomatic HIV-1-infected patients after HIV-DNA immunization followed by highly active antiretroviral treatment. J Immunol (1999) 0.90
Increased activation and altered ratio of interferon-gamma: interleukin-4 secreting cells in MRL-lpr/lpr mice. Autoimmunity (1995) 0.90
Altered frequency of type 1 cytokine secreting cells in the peripheral blood of patients with primary Sjögren's syndrome. J Rheumatol (1998) 0.90
DNAse treatment does not improve the survival of lupus prone (NZB x NZW)F1 mice. Lupus (1998) 0.90
Analysis of the promoter and cis-acting elements regulating expression of herpes simplex virus type 2 latency-associated transcripts. J Virol (1995) 0.90
Effect of HIV infection on the frequency of cytokine-secreting cells in human peripheral blood. AIDS Res Hum Retroviruses (1996) 0.90
IFN-gamma is a potent inducer of Ig secretion by sort-purified murine B cells activated through the mIg, but not the CD40, signaling pathway. Int Immunol (1996) 0.89
The natural history of disease expression in CD4 and CD8 gene-deleted New Zealand black (NZB) mice. J Immunol (1996) 0.89
The comparative biology of latent herpes simplex virus type 1 and type 2 infections: latency-associated transcript promoter activity and expression in vitro and in infected mice. J Neurovirol (1998) 0.89
Factors associated with the development of neonatal tolerance after the administration of a plasmid DNA vaccine. J Immunol (1999) 0.88
Effects of bacterial DNA on cytokine production by (NZB/NZW)F1 mice. J Immunol (1998) 0.87
Idiotypy and autoimmunity. Arthritis Rheum (1986) 0.85
Genetic studies in NZB mice. VI. Association of autoimmune traits in recombinant inbred lines. J Immunol (1984) 0.84
Response of porcine peripheral blood mononuclear cells to CpG-containing oligodeoxynucleotides. Vet Microbiol (2001) 0.84
Contribution of interleukin-3 to antigen-induced Th2 cytokine production. Eur J Immunol (1996) 0.84
Positive and negative regulatory elements contribute to CpG oligonucleotide-mediated regulation of human IL-6 gene expression. Eur J Immunol (2000) 0.83
Use of a novel virus detection assay to identify coronavirus HKU1 in the lungs of a hematopoietic stem cell transplant recipient with fatal pneumonia. Transpl Infect Dis (2011) 0.83
Activity and safety of DNA plasmids encoding IL-4 and IFN gamma. Gene Ther (1999) 0.83
CpG ODN-mediated regulation of IL-12 p40 transcription. Eur J Immunol (2000) 0.83
The regulation of DNA vaccines. Curr Opin Biotechnol (2001) 0.82
Abnormal numbers of cytokine producing cells in patients with polymyositis and dermatomyositis. Clin Exp Rheumatol (1997) 0.82
Prevention of neonatal tolerance by a plasmid encoding granulocyte-macrophage colony stimulating factor. Vaccine (1999) 0.80
Quantitation of autoantibody-secreting B cells in systemic lupus erythematosus. Autoimmunity (1989) 0.80
Long-term effect of primary immunization on subsequent immune responsiveness. Cell Immunol (1997) 0.79
Modulation of c-myb transcription in autoimmune disease by cyclophosphamide. J Immunol (1985) 0.79
Preserving primary cDNA libraries. Anal Biochem (1987) 0.79
Dialyzable serum components can support the growth of hybridoma cell lines in vitro. J Immunol Methods (1981) 0.78
Analysis of B-cell subpopulations. I. Relationships among splenic xid, Ly 1+, and Lyb 5+ B cells. Cell Immunol (1985) 0.78
Immunization with recombinant gp160 prolongs the survival of HIV-1 transgenic mice. AIDS Res Hum Retroviruses (1993) 0.78
Effect of anti-Ia treatment on the production of anti-DNA antibody by NZB mice. Eur J Immunol (1986) 0.78
Lack of correlation between the number of circulating B cells and the concentration of serum antibodies reactive with the HIV-1 envelope glycoprotein. J Acquir Immune Defic Syndr (1994) 0.77
Administration of a phosphorothioate oligonucleotide antisense to murine endogenous retroviral MCF env causes immune effects in vivo in a sequence-specific manner. Clin Immunol Immunopathol (1993) 0.77
Genetic and molecular genetic studies of murine and human lupus. J Rheumatol Suppl (1987) 0.77
Contribution of mast cells to the T helper 2 response induced by simultaneous subcutaneous and oral immunization. Immunology (1999) 0.76